Verification evidence is still being completed.
Adamed Pharma S.A.
Pienkow, Poland
- Verified lead
- Piotr Korycki
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- President of the Management Board and Chief Executive Officer
- 2026 technical specialization
- Integrated Pharmaceutical R&D and Manufacturing, Oncology, Cardiology, CNS, and Respiratory
- Review cycle
- 24 April 2026
- Full address
- ul. Mariana Adamkiewicza 6A, 05-152 Pienkow, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Adamed Pharma official site with corporate leadership information.
- Editorial note
- Integrated Polish pharmaceutical manufacturer with named CEO, EU-GMP operations, exports to more than 70 countries, and a public innovative biotech pipeline.
Integrated Pharmaceutical R&D and Manufacturing, Oncology, Cardiology, CNS, and Respiratory
EU-GMP manufacturing, Multiple ISO certifications, NorthData KRS registry record
Integrated Polish pharmaceutical manufacturer with named CEO, EU-GMP operations, exports to more than 70 countries, and a public innovative biotech pipeline.
Adamed Pharma S.A.
Integrated Pharmaceutical R&D and Manufacturing, Oncology, Cardiology, CNS, and Respiratory · Commercial pharmaceutical manufacturing
Integrated Polish pharmaceutical manufacturer with named CEO, EU-GMP operations, exports to more than 70 countries, and a public innovative biotech pipeline.
- Lead
- Piotr Korycki (verified ↗)
- Address
- ul. Mariana Adamkiewicza 6A, 05-152 Pienkow, Poland (source ↗)
- Compliance
- EU-GMP manufacturing
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Commercial pharmaceutical manufacturing
- Capabilities
- API and Finished-Dose Manufacturing · Oncology, Cardiology, CNS, and Respiratory Portfolios · Innovative Biotech Pipeline
- Founded
- 1986
- Headcount
- 1001-5000
- Company page (open ↗)
Piotr Korycki
President of the Management Board and Chief Executive Officer
ALEO KRS directory listing Adamed Pharma at Mariana Adamkiewicza 6A in Pienkow.
Open sourceCommercial pharmaceutical manufacturing
Pienkow, Poland. Integrated Pharmaceutical R&D and Manufacturing, Oncology, Cardiology, CNS, and Respiratory. Review completed on 24 Apr 2026.
Polish Office for Registration of Medicinal Products and EMA for pharmaceutical oversight
EU-GMP manufacturing, Multiple ISO certifications, NorthData KRS registry record
Integrated Pharmaceutical R&D and Manufacturing, Oncology, Cardiology, CNS, and Respiratory
Integrated Polish pharmaceutical manufacturer with named CEO, EU-GMP operations, exports to more than 70 countries, and a public innovative biotech pipeline.
Adamed Pharma is a large integrated Polish pharmaceutical company with a named CEO, EU-GMP and multiple ISO certifications, an innovative biotech pipeline, and exports to more than 70 countries.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
Verification history
Frequently asked questions
- Where is Adamed Pharma S.A. located?
- Adamed Pharma S.A. operates from ul. Mariana Adamkiewicza 6A, 05-152 Pienkow, Poland, Pienkow, Poland.
- Who runs Adamed Pharma S.A.?
- Adamed Pharma S.A. is led by Piotr Korycki, President of the Management Board and Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does Adamed Pharma S.A. hold?
- Adamed Pharma S.A. is documented under EU-GMP manufacturing.
- What does Adamed Pharma S.A. do?
- Integrated Polish pharmaceutical manufacturer with named CEO, EU-GMP operations, exports to more than 70 countries, and a public innovative biotech pipeline. Core capabilities: API and Finished-Dose Manufacturing, Oncology, Cardiology, CNS, and Respiratory Portfolios, Innovative Biotech Pipeline.
Related technical briefs
Briefs that name Pienkow as a covered market or city.
